AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas

Matthew L. Bush(University of Toledo), Abraham Jacob(Nationwide Children's Hospital)
Neuro-Oncology
July 21, 2011
Cited by 80


Related Papers

No related papers found

Powered by citation graph analysis